Neurodiversity in the workplace is one of the most consequential — and most poorly managed — occupational health challenges of our time. Fifteen million people in the UK are neurodivergent. Most are in employment. The majority are unsupported, misunderstood, or managing entirely alone. The cost to employers — in tribunal risk, lost productivity, retention, and reputational damage — is measurable and growing.
Allo Workplace was built on a simple clinical premise: that functional need, not formal diagnosis, is the correct basis for workplace support. It introduces a structured occupational health assessment process — grounded in Equality Act 2010 principles — that enables employers to meet their legal duties and employees to be genuinely heard, without requiring either party to navigate the broken UK and global diagnostic pathway first.
The impact is two-directional. For the neurodivergent employee, it creates a voice: a clinically-designed framework that captures their functional reality at work in their own words, generates a professional occupational health-style report, and routes that report to the people who can act on it. For the employer, it creates the documented, legally defensible process that transforms a potential liability into a demonstrable duty of care.